Perspectives on perfusion monitoring in septic shock after the ANDROMEDA-SHOCK trial

2019 ◽  
Vol 43 (9) ◽  
pp. 578-581
Author(s):  
G. Hernández ◽  
J. Bakker
Keyword(s):  
Septic Shock ◽  
Shock Trial

Factors associated with non-response at health-related quality of life follow-up in a septic shock trial

2017 ◽  
Vol 62 (3) ◽  
pp. 357-366 ◽  
Author(s):  
M. N. Kjaer ◽  
C. B. Mortensen ◽  
P. B. Hjortrup ◽  
S. L. Rygård ◽  
I. Andersen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Septic Shock ◽  
Shock Trial ◽  
Health Related Quality ◽  
Factors Associated ◽  
Related Quality ◽  
Health Related

scholarly journals Systematic assessment of fluid responsiveness during early septic shock resuscitation: secondary analysis of the ANDROMEDA-SHOCK trial

Critical Care ◽  
2020 ◽  
Vol 24 (1) ◽  
Author(s):  
Eduardo Kattan ◽  
◽  
Gustavo A. Ospina-Tascón ◽  
Jean-Louis Teboul ◽  
Ricardo Castro ◽  
...  
Keyword(s):  
Septic Shock ◽  
Fluid Responsiveness ◽  
Secondary Analysis ◽  
Shock Trial ◽  
Systematic Assessment

Perspectives on perfusion monitoring in septic shock after the ANDROMEDA-SHOCK trial

2019 ◽  
Vol 43 (9) ◽  
pp. 578-581 ◽  
Author(s):  
G. Hernández ◽  
J. Bakker
Keyword(s):  
Septic Shock ◽  
Shock Trial

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

2018 ◽  
pp. 79-84
Author(s):  
Karim Fikry
Keyword(s):  
Septic Shock ◽  
Study Design ◽  
Shock Trial ◽  
Suggested Approach ◽  
Norepinephrine Infusion ◽  
Secondary Outcomes ◽  
Post Hoc ◽  
The Impact

The Vasopressin and Septic Shock Trial (VASST) compares the use of vasopressin to norepinephrine in patients with septic shock. This chapter includes an overview of the study design and interventions. It also outlines the primary and secondary outcomes used in this trial, as well as the results found. It also discusses some criticisms and limitations of the study. To help readers fully understand the impact of the VASST, this chapter includes a quick review of several post hoc analyses from the trial as well as other relevant studies, including some important post hoc analyses, in addition to other related studies. Finally, this chapter concludes with a case example and a suggested approach on how to clinically apply the results of the VASST.

Establishing a master cell bank of bone marrow-derived mesenchymal stem cells for the cellular immunotherapy for septic shock trial (CISS)

Cytotherapy ◽  
2015 ◽  
Vol 17 (6) ◽  
pp. S50
Author(s):  
Shirley H. Mei ◽  
Mahmoud Salkhordeh ◽  
Saad Khan ◽  
Samantha Hodgins ◽  
Irene Watpool ◽  
...  
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Septic Shock ◽  
Mesenchymal Stem Cells ◽  
Cellular Immunotherapy ◽  
Shock Trial ◽  
Cell Bank ◽  
Master Cell Bank

Corticosteroids and the original vasopressin and septic shock trial subgroups

2010 ◽  
Vol 38 (1) ◽  
pp. 338-339 ◽  
Author(s):  
James A. Russell ◽  
Anthony C. Gordon ◽  
Keith R. Walley
Keyword(s):  
Septic Shock ◽  
Shock Trial
Sign in / Sign up

Export Citation Format

Share Document